A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

NCT00637481 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

NIH

Sponsor class

Conditions

Atypical Ductal Breast Hyperplasia
Breast Cancer
Ductal Breast Carcinoma in Situ
Lobular Breast Carcinoma in Situ

Interventions

DRUG: atorvastatin calcium
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)